Cross-talk between mesenchyme and epithelium increases H19 gene expression during scattering and morphogenesis of epithelial cells

被引:36
作者
Adriaenssens, E
Lottin, S
Berteaux, N
Hornez, L
Fauquette, W
Fafeur, V
Peyrat, JP
Le Bourhis, XF
Hondermarck, H
Coll, J
Dugimont, T
Curgy, JJ [1 ]
机构
[1] USTL, Dev Biol Lab, UPRESEA 1033, F-59655 Villeneuve Dascq, France
[2] IBL, Lab Immunol Cellulaire Malad Infect, CNRS, UMR 8527, F-59021 Lille, France
[3] Ctr Oscar Lambret, Lab Oncol Mol Humaine, F-59020 Lille, France
[4] IBL, CNRS, FRE 2353, F-59021 Lille, France
关键词
H19; gene; epithelium-mesenchyme interactions; scattering; morphogenesis; extracellular matrix; HGF/SF;
D O I
10.1006/excr.2002.5500
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The H19 gene is an imprinted gene expressed from the maternal allele. It is known to function as an RNA molecule. We previously reported that in breast adenocarcinoma, H19 is often overexpressed in stromal cells and preferentially located at the epithelium/stroma boundary, suggesting that epithelial/mesenchymal interactions can control H19 RNA expression. In some cases of breast adenocarcinoma with poor prognosis, H19 is overexpressed in epithelial cells. Therefore we examined whether mesenchymal factors can induce H19 expression in epithelial cells. Using quantitative RT-PCR and in situ hybridization, we found that when mammary epithelial cells were cultured in collagen gels, H19 expression was strongly up-regulated compared to when cells were cultured on plastic. Collagen gels allow three-dimensional growth of epithelial cells and morphogenetic responses to soluble factors. A conditioned medium from MRC-5 fibroblasts caused branching morphogenesis of HBL-100 cells and invasive growth of MDA-MB-231 cells, whereas MCF-7 cells were unresponsive. Induction of H19 expression correlated with morphological changes in HBL-100 and in MDA-MB-231 cells, whereas H19 expression was not induced in MCF-7 cells. Using a blocking antibody, HGF/SF was identified as the fibroblast-derived growth factor capable of inducing H19 expression and cell morphogenesis. We further demonstrated that H19 promoter activity was stimulated by various growth factors using transient transfection in MDCK epithelial cells. HGF/SF was more efficient than EGF or FGF-2 in transactivating the H19 promoter, whereas IGF-2, TGFbeta-1, and TNF-alpha were ineffective. This activation by HGF/SF was prevented by pharmacological inhibition of MAP kinase or of phospholipase C. We conclude that H19 is a target gene for HGF/SF, a known regulator of epithelial/mesenchymal interactions, and suggest that the up-regulation of H19 may be implicated in morphogenesis and/or migration of epithelial cells. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:215 / 229
页数:15
相关论文
共 105 条
  • [1] Adam GIR, 1996, DEVELOPMENT, V122, P839
  • [2] H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression
    Adriaenssens, E
    Dumont, L
    Lottin, S
    Bolle, D
    Leprêtre, A
    Delobelle, A
    Bouali, F
    Dugimont, T
    Coll, J
    Curgy, JJ
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (05) : 1597 - 1607
  • [3] Steroid hormones modulate H19 gene expression in both mammary gland and uterus
    Adriaenssens, E
    Lottin, S
    Dugimont, T
    Fauquette, W
    Coll, J
    Dupouy, JP
    Boilly, B
    Curgy, JJ
    [J]. ONCOGENE, 1999, 18 (31) : 4460 - 4473
  • [4] The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma
    Ariel, I
    Sughayer, M
    Fellig, Y
    Pizov, G
    Ayesh, S
    Podeh, D
    Libdeh, BA
    Levy, C
    Birman, T
    Tykocinski, ML
    de Groot, N
    Hochberg, A
    [J]. JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2000, 53 (06): : 320 - 323
  • [5] The product of the imprinted H19 gene is an oncofetal RNA
    Ariel, I
    Ayesh, S
    Perlman, EJ
    Pizov, G
    Tanos, V
    Schneider, T
    Erdmann, VA
    Podeh, D
    Komitowski, D
    Quasem, AS
    deGroot, N
    Hochberg, A
    [J]. JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1997, 50 (01): : 34 - 44
  • [6] Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma
    Ariel, I
    Miao, HQ
    Ji, XR
    Schneider, T
    Roll, D
    de Groot, N
    Hochberg, A
    Ayesh, S
    [J]. JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1998, 51 (01): : 21 - 25
  • [7] Association of IGF2 and H19 imprinting with choriocarcinoma development
    Arima, T
    Matsuda, T
    Takagi, N
    Wake, N
    [J]. CANCER GENETICS AND CYTOGENETICS, 1997, 93 (01) : 39 - 47
  • [8] EPIGENETIC MECHANISMS UNDERLYING THE IMPRINTING OF THE MOUSE H19-GENE
    BARTOLOMEI, MS
    WEBBER, AL
    BRUNKOW, ME
    TILGHMAN, SM
    [J]. GENES & DEVELOPMENT, 1993, 7 (09) : 1663 - 1673
  • [9] The protein CTCF is required for the enhancer blocking activity of vertebrate insulators
    Bell, AC
    West, AG
    Felsenfeld, G
    [J]. CELL, 1999, 98 (03) : 387 - 396
  • [10] Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
    Bell, AC
    Felsenfeld, G
    [J]. NATURE, 2000, 405 (6785) : 482 - 485